Products

What will AGI do for Alfuzosin hydrochloride?

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H27N5O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75046A1XTN, chemically known as 2-furancarboxamide, n-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)- but more generally known as alfuzosin hydrochloride, which bears US NIH Compound Identifier 71764. The base coompound, Alfuzosin, also comes in simple form. European Medicines Agency schedules Alfuzosin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00340MIG. Most nations, for tariff and trade purposes, schedule alfuzosin hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, ALFUZOSIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Alfuzosin hydrochloride bears US NLM identifiers UMLS ID C0102130 and NCI Concept Code C53408. SMILES: CN(CCCNC(=O)C1CCCO1)C2NC3CC(C(CC3C(N2)N)OC)OC.CL.